It's not possible to determine no matter whether these events are relevant directly to using PDE5 inhibitors, for the affected person's fundamental vascular hazard variables or anatomical defects, to a mix of these aspects, or to other elements [see WARNINGS AND Safeguards and PATIENT Details].It's also possible to try out complementary and substit